Eagle Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.7M | 1.0M | 3.73 |
| 2024-06-30 | $5.6M | 1.0M | 5.60 |
| 2024-03-31 | $14k | 2.7k | 5.24 |
| 2023-12-31 | $9.1k | 1.7k | 5.23 |
| 2023-09-30 | $3.2k | 203 | 15.77 |
| 2023-03-31 | $210k | 7.4k | 28.37 |
| 2022-12-31 | $987k | 34k | 29.23 |
| 2022-09-30 | $1.5M | 58k | 26.43 |
| 2021-12-31 | $1.8M | 36k | 50.93 |
| 2021-03-31 | $1.8M | 43k | 41.73 |
| 2020-12-31 | $340k | 7.3k | 46.54 |
| 2020-09-30 | $312k | 7.3k | 42.48 |
| 2020-06-30 | $826k | 17k | 47.96 |
| 2020-03-31 | $610k | 13k | 45.95 |
| 2019-12-31 | $457k | 7.6k | 60.06 |
| 2019-09-30 | $1.1M | 19k | 56.62 |
| 2019-06-30 | $284k | 5.1k | 55.66 |
| 2019-03-31 | $301k | 5.9k | 50.53 |
| 2018-12-31 | $4.5M | 112k | 40.29 |
| 2018-09-30 | $3.3M | 48k | 69.31 |
| 2018-06-30 | $2.8M | 37k | 75.66 |
| 2018-03-31 | $2.5M | 47k | 53.44 |
| 2017-12-31 | $2.4M | 45k | 53.41 |
| 2017-09-30 | $2.9M | 49k | 59.64 |
| 2017-06-30 | $2.7M | 34k | 78.89 |
| 2017-03-31 | $1.6M | 19k | 82.95 |
| 2016-12-31 | $5.9M | 74k | 79.34 |
| 2016-09-30 | $559k | 8.0k | 70.04 |
| 2016-06-30 | $12k | 305 | 39.34 |
| 2015-12-31 | $94k | 1.1k | 88.68 |
| 2015-09-30 | $439k | 5.9k | 74.01 |
| 2015-06-30 | $9.0k | 111 | 81.08 |
| 2014-09-30 | $0 | 14 | 0.00 |